January 6, 2009 - By Krista Conger
The California Institute for Regenerative Medicine on Dec. 10 awarded $949,608 to Helen Blau, PhD, the Donald E. and Delia B. Baxter Professor of Pharmacology, in the agency's latest round of grants, dedicated to developing new stem cell research techniques.
Blau's grant is to improve the ability to observe and direct how stem cells grow and change into other cell types. Her lab will study mouse muscle stem cells isolated in 'microwells' and characterize how they change when exposed to various factors. It will also monitor changes in the cells with a bioluminescent marker she developed. The goal is to develop new tools for characterizing these cells.
With this grant from CIRM, Stanford has thus far received about $95 million from the state agency, more than any other single institution.
-
Krista CongerKrista Conger is a science writer for the medical school’s Office of Communication & Public Affairs.
About Stanford Medicine
Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.
